Advancement in computational simulation and validation of congenital heart disease: a review

Ahmad Fikri Azfar Ahmad Azahari1, Wan Naimah Wan Ab Naim1, Nor Ashikin Md Sari2

  • 1Faculty of Manufacturing and Mechatronic Engineering Technology, Universiti Malaysia Pahang, Pekan, Pahang, Malaysia.

Insights

Computational modeling aids in assessing long-term congenital heart disease (CHD) treatment efficacy. Advanced multiscale and multiphysics simulations, along with 3D printing and PIV, enhance accuracy and future applications.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Computational Science

Background:

  • Improved congenital heart disease (CHD) management has increased infant survival rates.
  • Assessing the long-term effectiveness of CHD treatments remains challenging.
  • Computational modeling offers a powerful tool for evaluating treatment outcomes in CHD.

Purpose of the Study:

  • To provide a comprehensive overview of computational modeling applications in CHD.
  • To categorize CHD computational models based on affected structures (large blood vessels, heart chambers, multiple structures).
  • To discuss advancements, future directions, and validation techniques for CHD computational modeling.

Main Methods:

  • Review of existing literature on computational modeling in CHD.
  • Categorization of models based on anatomical involvement in CHD.
  • Highlighting multiscale and multiphysics modeling approaches.
  • Discussion of proposed validation techniques including 3D printing and particle image velocimetry (PIV).

Main Results:

  • Computational modeling effectively evaluates CHD, categorized by affected structures.
  • Multiscale and multiphysics modeling provide a complete representation of cardiac function and circulation.
  • Future directions include incorporating growth, remodeling, detailed conduction systems, and myocardial infarction.

Conclusions:

  • Computational modeling is crucial for assessing long-term CHD treatment efficacy.
  • Advanced simulation techniques and validation methods are vital for improving model accuracy.
  • Further development in computational CHD modeling promises enhanced patient care and outcomes.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...